| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702298 | Practical Radiation Oncology | 2017 | 6 Pages |
Abstract
ADT with moderate HypoRT delivered with IMRT and an integrated simultaneous boost to the prostate (60 Gy) and pelvic nodes (44 Gy) in 20 fractions is feasible and well tolerated. This approach shortens treatment duration and is convenient for patients and the health system, and its results support a randomized trial.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sergio MD, PhD, Russel PhD, Fabio MD, Marie MD, Luis MD, FASTRO,